April 28, 2022
Video
Lori A. Leslie, MD, discusses the impact that brexucabtagene autoleucel had on the treatment landscape for patients with relapsed or refractory mantle cell lymphoma.
February 25, 2022
Video
Lori A. Leslie, MD, discusses her recent presentation around chimeric antigen receptor T-cell therapy for mantle cell lymphoma and indolent lymphomas.
October 06, 2020
Video
Lori A. Leslie, MD, discusses the approval of tazemetostat in the follicular lymphoma setting and the data that that led to its FDA approval.
August 19, 2020
Video
Lori A. Leslie, MD, discusses the current treatment options for patients with mantle cell lymphoma.
July 23, 2020
Video
Lori A. Leslie, MD, discusses options for patients with relapsed/refractory mantle cell lymphoma.
February 25, 2020
Video
Lori A. Leslie, MD, discusses chimeric antigen receptor T-cell therapy as a treatment for diffuse large B-cell lymphoma and the positive results demonstrated for this agent in patients with relapsed/refractory disease.